These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6142587)

  • 21. Effects of a series of substituted benzamides on rat prolactin secretion and 3H-spiperone binding to bovine anterior pituitary membranes.
    Meltzer HY; Simonovic M; So R
    Life Sci; 1983 Jun; 32(25):2877-86. PubMed ID: 6855475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulpiride: assessment of a pharmacologically and chemically distinct neuroleptic.
    Rich TD
    Med Hypotheses; 1984 May; 14(1):69-81. PubMed ID: 6146915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    Life Sci; 1978 Aug; 23(6):545-9. PubMed ID: 692279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors.
    Chivers JK; Gommeren W; Leysen JE; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Jun; 40(6):415-21. PubMed ID: 2901473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropharmacological and behavioural properties of remoxipride in the rat.
    Ogren SO; Florvall L; Hall H; Magnusson O; Angeby-Möller K
    Acta Psychiatr Scand Suppl; 1990; 358():21-6. PubMed ID: 1978483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.
    Dawbarn D; Pycock C
    Eur J Pharmacol; 1981 May; 71(2-3):233-45. PubMed ID: 6113967
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.
    Rumigny JF; Strolin Benedetti M; Dostert P
    J Pharm Pharmacol; 1984 Jun; 36(6):373-7. PubMed ID: 6146667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain.
    Hall H; Köhler C; Gawell L
    Eur J Pharmacol; 1985 May; 111(2):191-9. PubMed ID: 4018125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.
    Terai M; Usuda S; Kuroiwa I; Noshiro O; Maeno H
    Jpn J Pharmacol; 1983 Aug; 33(4):749-55. PubMed ID: 6138453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
    Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.
    Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.